Atrophic vaginitis, Concordance and interpretation of slides in the college of American pathologists cervicovaginal interlaboratory comparison program in gynecologic cytopathology

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 11, 2012, Pages 1332-1338

  Crothers, Barbara A ^a   Booth, Christine N ^b   Darragh, Teresa M ^c   Means, Marilee M ^d   Ma, Ly ^e   Souers, Rhona J ^f   Thomas, Nicole ^f   Moriarty, Ann T ^g  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^e RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f North Carolina   (United States)

^g Department of Pathology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATROPHIC VAGINITIS; COMPARATIVE STUDY; DIAGNOSTIC ERROR; EDUCATION; EVALUATION; FEMALE; HUMAN; LABORATORY; MEDICAL SOCIETY; METHODOLOGY; NEUTROPHIL; OBSERVER VARIATION; PATHOLOGY; PROSPECTIVE STUDY; STATISTICS; UNITED STATES; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ATROPHIC VAGINITIS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DIAGNOSTIC ERRORS; FEMALE; HUMANS; LABORATORIES; NEUTROPHILS; OBSERVER VARIATION; PATHOLOGY, CLINICAL; PROSPECTIVE STUDIES; SOCIETIES, MEDICAL; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84870954012     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0441-CP     Document Type: Article

References (18)

1. Solomon D, Nayar R, eds. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. 2nd ed. New York, NY: Springer-Verlag; 2004.
2. Pandit L, Ouslander JG. Postmenopausal vaginal atrophy and atrophic vaginitis. Am J Med Sci. 1997;314(4):228-231.
3. Capewell AE, McIntyre MA, Elton RA. Post-menopausal atrophy in elderly women: is a vaginal smear necessary for diagnosis? Age Ageing. 1992;21(2):117- 120.
4. DeMay RM. The Art and Science of Cytopathology, Volume I-Exfoliative Cytology. Hong Kong, China: ASCP Press; 1996.
5. Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Juliá MD. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas. 2005; 52(suppl 1): S46-S52.
6. Lynch C. Vaginal estrogen therapy for the treatment of atrophic vaginitis. J Women's Health (Larchmt). 2009;18(10):1595-1606.
7. Moriarty AT, Clayton AC, Zaleski S, et al. Unsatisfactory reporting rates: 2006 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology. Arch Pathol Lab Med. 2009;133(12):1912-1916.
8. Renshaw AA, Mody DR, Wang E, et al. Hyperchromatic crowded groups in cervical cytology-differing appearances and interpretations in conventional and ThinPrep preparations: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2006;130(3):332-336.
9. Patton AL, Duncan L, Bloom L, Phaneuf G, Zafar N. Atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion and its clinical significance in postmenopausal, pregnant, postpartum, and contraceptive-use patients. Cancer. 2008;114(6):481-488.
10. Selvaggi SM. Atrophic vaginitis versus invasive squamous cell carcinoma on ThinPrep cytology: can the background be reliably distinguished? Diagn Cytopathol. 2002;27(6):362-364.
11. Keating JT, Wang HH. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women. Cancer. 2001;93(2):100-105.
12. Greendale GA, Zibecchi L, Petersen L, Ouslander JG, Kahn B, Ganz PA. Development and validation of a physical examination scale to assess vaginal atrophy and inflammation. Climacteric. 1999;2(3):197-204.
13. Repse-Fokter A, Takac I, Fokter SK. Postmenopausal vaginal atrophy correlates with decreased estradiol and body mass index and does not depend on the time since menopause. Gynecol Endocrinol. 2008;24(7):399-404.
14. Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines: the detection and management of vaginal atrophy. Int J Gynaecol Obstet. 2005;88(2):222-228.
15. Bateson DJ, Weisberg E. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the presence of atrophic changes reported in postmenopausal cervical smears. Menopause. 2009;16(4): 765-769.
16. Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of lowdose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized control trial. Obstet Gynecol. 2008;111(1):67-76.
17. Gupta S, Kumar N, Singhal N, Manektala U, Jain S, Sodhani P. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy. Diagn Cytopathol. 2006;34(10):676-681.
18. Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, Department of Health and Human Services. Medicare, Medicaid, and CLIA programs; laboratory requirements relating to quality systems and certain personnel qualifications: final rule. Fed Regist. 2003; 68(16):3711. To be codified at 42 CFR 1493.1274(e)(1).